Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people take four to eight weeks to get used to Wegovy. The first pen brings a lower starter dose designed to let your body adjust gradually, and for many people the side effects that feel sharpest in week one settle noticeably by week three or four. That said, everyone's adjustment period is different, and some people find the early weeks smoother than they expected. Wegovy is a prescription-only medicine, and a prescriber decides whether it is clinically appropriate for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've just done your first Wegovy injection, the 0.25 mg starter pen, and within a day or two the nausea arrives. Maybe a low-grade queasiness that sits just below the surface, maybe something sharper after meals. This is the most commonly reported experience, and it has a straightforward explanation. Semaglutide slows gastric emptying — food lingers longer in the stomach than your digestive system is used to — and it acts on receptors in the brain that regulate appetite and nausea simultaneously. Your system hasn't calibrated to that yet.
The NHS patient information for semaglutide lists nausea, vomiting, diarrhoea and constipation as the most common side effects, with a note that they are usually most noticeable when starting or after a dose increase. That framing matters: most noticeable, not permanent. Fatigue and headache also appear in the first week for some people, likely a combination of reduced calorie intake and the body adjusting to the medicine's signalling effects.
Small, frequent meals rather than large ones tend to help. Fatty, spicy or very rich foods are harder for a slowed stomach to process. Staying hydrated matters more than it might seem, especially if nausea is putting you off drinking as well as eating. Most people find week one is the hardest, and week two already feels a little easier. If it does not ease, or if you are unable to keep fluids down, contact your prescribing team rather than pushing through.
By the second or third week at the starter dose, most people report a noticeable shift. The nausea becomes background rather than foreground. Appetite starts to change in a way that feels less like a side effect and more like an effect: smaller portions feel sufficient, the pull toward snacking diminishes, and the urge to eat past fullness (something many people describe as a compulsion rather than a choice) begins to quieten. This is the medicine doing its licensed job.
It is worth knowing that semaglutide's pharmacokinetics mean it takes roughly four to five weeks to reach a steady concentration in the body at any given dose. So the full appetite-suppressing effect of 0.25 mg is not really felt until near the end of that first four-week pen. If you are wondering how long it takes to get Wegovy in the first place, that page covers the prescription and delivery process from the start. You can read more about the typical weight-loss timeline on our page covering how long Wegovy takes to produce weight loss.
The dose increase to 0.5 mg at week five brings a second, often milder, version of that initial adjustment. Many people find the step-up responses get shorter each time, because the body has already encountered the mechanism and partially adapted. Not everyone experiences this, but it is a common pattern in clinical practice.
The full titration schedule runs from 0.25 mg up through 0.5 mg, 1.0 mg, 1.7 mg, and eventually to 2.4 mg, with roughly four weeks at each rung. That means most people reach the maintenance dose around the five-month mark. Each increase can bring a short adjustment window, typically three to ten days of returned GI symptoms, before settling again. If you are trying to time a dose increase away from a holiday or a heavy work week, that is a practical thing to raise with your prescriber. Payday, a Monday order, a trip planned for the end of the month, these are real scheduling questions people bring to consultations, and there is no harm in asking.
The STEP 1 trial, published in the New England Journal of Medicine, studied semaglutide 2.4 mg across 68 weeks. Average weight reduction was around 15%. Most of that loss accrued gradually over the first year, with the rate of change slowing as the body reached a new equilibrium. Getting used to the medicine and getting results from it are parallel processes rather than sequential ones. You can explore the fuller evidence picture on the Wegovy weight-loss timeline page.
If side effects at a step-up feel disproportionate or last beyond two weeks at the new dose, a prescriber may suggest staying at the current dose for longer before increasing. This is a legitimate clinical option, not a failure. Treatment belongs to you and the prescriber together. Our clinical team overview is on the clinical team page if you want to understand who reviews consultations at nume.
For most people, by months two to three (around the 1.0 mg mark) the experience of being on Wegovy has become unremarkable day-to-day. The injections are routine. The appetite changes feel like their baseline rather than a pharmaceutical effect. Many people describe forgetting they are on treatment until they notice the clothes fitting differently or the scales moving. That habituation is not a sign the medicine has stopped working. It is the ordinary experience of a weekly drug whose effects become integrated into daily life.
If you are still finding the adjustment difficult at month two or beyond, or if symptoms are affecting your quality of life significantly, a prescriber should hear about it. That is exactly what aftercare is for. You can read more about what to expect from the medicine overall on the Wegovy treatment page, or see how Wegovy works in the earlier phases on this page covering how quickly it takes effect. Questions about costs and what is included in a private prescription are covered on the Wegovy price comparison page. When you are ready to have your eligibility assessed by a prescriber, you can start a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.